Skip to content

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

Date: August 12, 2025

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the session “Overcoming AI Hype for Realised ROI: Taking a Problem-Centred Approach to Enterprise Transformation” confronted this challenge head-on.

Led by Jason Housley (eClinical Solutions), the discussion pulled no punches on why stubborn timelines persist despite decades of “next-gen” innovation – from blockchain to wearables to today’s AI.

Drawing on industry survey data, real-world case studies, and his “Golden Rules” for sustainable transformation, Jason shared how organisations can cut through the buzz and focus on the problems that truly matter – delivering tangible, measurable results rather than symbolic go-lives.

Read the session summary for key takeaways – pragmatic, experience-based, and laser-focused on turning AI potential into real ROI.

Click here to read

 

 


 

Explore More News

Welcome The Institute of Cancer Research – Scientific Computing as a corporate member

The Association for Clinical Data Management (ACDM) is delighted to welcome The Institute . . .

Read More

Newsletter Committee: Meet Federica

The ACDM is delighted to welcome Federica Migliore of IQVIA to the Newsletter . . .

Read More

Welcome P95 as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome P95 as a new . . .

Read More

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .

Read More

Newsletter Committee: Meet Neha

The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee. Neha shares . . .

Read More

Newsletter Committee: Meet Sylvain

The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .

Read More

Welcome VHypotenuse as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .

Read More

Newsletter Committee: Meet Marta

The ACDM is delighted to welcome Marta Kowalska of CluePoints to the Newsletter . . .

Read More

AI model trained on de-identified data from 57 million people

Researchers at UCL have trained an AI model using de-identified data from 57 million . . .

Read More

ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released

The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and . . .

Read More

ICH E6(R3) Guideline reaches Step 4 of the ICH Process

ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025. The guideline . . .

Read More

U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties

The U.S. Food and Drug Administration has issued its first guidance on the use of . . .

Read More